Regnum

Regnum Market capitalization

The The market capitalization of Regnum (RGMP) as of Nov 22, 2026 is 22.95 USD. In the previous year, The market capitalization was 22.95 USD — a change of 0.00% (lower).

Market capitalization

22.95USD

YoY

0.00%

Last updated:

In 2022, Regnum's market cap stood at 22.95 USD, a 0.00% increase from the 22.95 USD market cap in the previous year.

The Regnum Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2016
22.95 USD
Jan 1, 2017
22.95 USD
Jan 1, 2018
22.95 USD
Jan 1, 2019
22.95 USD
Jan 1, 2020
22.95 USD
Jan 1, 2021
22.95 USD
Jan 1, 2022
22.95 USD
The Regnum Market capitalization history
YEARMarket capitalizationYoY
22.95USD0.00%
22.95USD0.00%
22.95USD0.00%
22.95USD0.00%
22.95USD0.00%
22.95USD0.00%
22.95USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Regnum Stock analysis

What does Regnum do? Regnum Corp. generates revenue through the commercialization of leronlimab (PRO 140), a monoclonal antibody targeting the CCR5 receptor for HIV treatment. The company holds exclusive U.S. commercial rights to leronlimab for all HIV indications, focusing on entry inhibitor therapies that block R5 strains of HIV from entering cells. Its primary product targets patients with HIV infections requiring CCR5-based treatment options, with the therapeutic positioned as a specialized solution within the rare disease and infectious disease markets. Leronlimab (PRO 140) is developed as a monoclonal antibody that binds to CCR5, preventing HIV from using this receptor as an entry point into healthy cells. This mechanism classifies it under entry inhibitors, a subset of HIV therapies. The company's revenue stream is directly tied to the U.S. market for leronlimab, where it holds exclusive commercial rights, serving patients and healthcare providers seeking alternatives to standard HIV treatments. Regnum is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Regnum's Market Capitalization

Regnum's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Regnum's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Regnum's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Regnum’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Regnum stock

The market capitalization of Regnum is 22.95 USD in 2022.

The market capitalization of Regnum changed from 22.95 USD to 22.95 USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Regnum since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Regnum with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Regnum

All Key Metrics — Regnum